Announcements Trials
Browse Landscape

Status

Completed 35Recruiting 27Unknown 18Active not recruiting 8Terminated 4Withdrawn 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Papillomavirus Infections 1

Interventions

Blood Specimen Collection 17Surveys and Questionnaires 14Psychiatric Rehabilitation 7Therapeutics 6Polymerase Chain Reaction 5Interviews as Topic 5Immunohistochemistry 5Gene Expression Profiling 5Biopsy 5Radiotherapy 4Magnetic Resonance Spectroscopy 4High-Energy Shock Waves 4Reverse Transcriptase Polymerase Chain Reaction 3Microarray Analysis 3Fluorodeoxyglucose F18 3Abiraterone Acetate 3Watchful Waiting 2Standard of Care 2Specimen Handling 2Prednisone 2Methods 2Leuprolide 2In Situ Hybridization, Fluorescence 2Hematologic Tests 2Glucose Tolerance Test 2Drug Therapy 2Comparative Genomic Hybridization 2Chemotherapy, Adjuvant 2Biopsy, Fine-Needle 2Bariatric Surgery 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Observational × Data Collection × Clear all
NCT01551537 2013-09-09

Post-marketing Surveillance of GSK Biologicals' Cervarixâ„¢ When Administered to Healthy Females in Sri Lanka

GlaxoSmithKline

Withdrawn

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡